Evidence map›Paper›PMID 40731887›Full record

Observational studyMedicina (Kaunas, Lithuania)2025

Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors.

Efraim Guzel, Ismail Hanta, Oya Baydar Toprak, Okan Gurbuz, Burak Mete, Ertugrul Bayram

Abstract readObservational Study
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Efraim GuzelDepartment of Chest Diseases, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.
Ismail HantaDepartment of Chest Diseases, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.ORCID 0000-0001-8610-2937
Oya Baydar ToprakDepartment of Chest Diseases, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.ORCID 0000-0001-7320-976X
Okan GurbuzDepartment of Chest Diseases, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.
Burak MeteDepartment of Public Health, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.ORCID 0000-0002-0780-6176
Ertugrul BayramDepartment of Medical Oncology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.ORCID 0000-0001-8713-7613

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immune Checkpoint InhibitorsLung DiseasesAgedBiomarkersFemaleHumansMaleMiddle AgedNeoplasmsProspective StudiesRisk FactorsBiomarkersImmune Checkpoint Inhibitorshypersensitivity pneumonitisimmune checkpoint inhibitorimmunotherapyinterstitial pneumoniaorganizing pneumoniapulmonary toxicity

Identifiers

PMID40731887
PMCPMC12298426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.